Results 231 to 240 of about 23,603,276 (341)

Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation. [PDF]

Transplant Direct
Manell E, Gunes ME, Merl S, Patwardhan S, Chauhan I, Hong J, Chen B, Jordache P, Almesalmy A, Ekanayake-Alper D, Hajosi D, Husain S, Wuu CS, Wright M, Bogue J, Rohde C, Shanmugarajah K, Cetrulo CL, Sachs DH, Weiner J.   +19 more
europepmc   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Molecular biology of the mouse Q region [PDF]

, 1987
Weiss, Elisabeth H., Elisabeth H. Weiss
core   +1 more source

The Novel Allele, HLA-C*14:167, With a Non-Synonymous Mutation in Exon 1. [PDF]

HLA
Kouniaki D, Athanassiades T, Tsirogianni A.   +2 more
europepmc   +1 more source

HLA Class I Histocompatibility Antigen, A-2 Alpha Chain [PDF]

, 2020
openaire   +1 more source

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

British Journal of Pharmacology, EarlyView.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source

The use of fusion proteins to study HLA-B27-specific allorecognition [PDF]

, 1989
Wildner, G., Szöts, Hannelore, Schendel, Dolores J., Weiss, Elisabeth H., Riethmüller, Gert   +4 more
core   +1 more source

Highlight of 2025: From binding prediction to molecular design-computational advances in TCR-pMHC prediction and targeting. [PDF]

Immunol Cell Biol
Maire KJ, Coquet JM.
europepmc   +1 more source

Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease

British Journal of Pharmacology, EarlyView.
Background and Purpose Degeneration of the pontine noradrenergic and midbrain dopaminergic systems contributes to cognitive‐behavioural disturbances during the prodromal stages of Alzheimer's disease (AD). We developed a genetically engineered, programmable probiotic Escherichia coli Nissle 1917 strain (EcNrhaL‐DOPA) capable of producing L‐3,4 ...
Mona Abdelhamid, Piyush Padhi, Mahsa Gifani, John S. Beck, Jacob P. Thomas, Gargi Khadse, Catherine Kudela, Gregory J. Phillips, Anumantha G. Kanthasamy, Scott E. Counts   +9 more
wiley   +1 more source

The Central Role of HLA Class II-Restricted Helper Neoantigen Vaccines in Cancer Immunotherapy. [PDF]

Cancers (Basel)
Morisaki T, Morisaki T.
europepmc   +1 more source